… improve the efficacy of anlotinb, we compared the efficacy of anlotinib plus immunotherapy
(… ) with anlotinib alone in NSCLC. There were 30 patients receiving anlotinib combined with …

… and to monitor post-marketing safety and adverse events. Citation7 In this study, we analyzed
the efficacy and safety of anlotinib in patients with advanced NSCLC in real-world settings. …

… performed, is safe, and can … anlotinib, and the efficacy and safety of the treatment were
assessed, with the primary observation endpoint being PFS. The results showed that anlotinib …

… The aim of this study was to investigate the efficacy and safety of anlotinib for patients
with … regimens in real world situations and the preliminary analysis of an efficacy predictor. …

… In conclusion, we elucidated the efficacy and safety of anlotinib in a real-world setting. Anlotinib
is effective in the treatment of advanced NSCLC, which can bring longer survival benefits …

… However, anlotinib may be preferred in clinical practice for … Furthermore, oral anlotinib
therapy during the coronavirus … Therefore, we investigated the efficacy and safety of anlotinib …

… , Anlotinib is also used in the second-line treatment of lung cancer. This study aims to evaluate
the efficacy of using Anlotinib in … in this study, 106 were in Anlotinib group and 61 were in …

… We explored the efficacy and safety of combination therapy with anlotinib and programmed
cell death protein 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) inhibitors as second-line …

… However, in practice, anlotinib is used not only in third-… anlotinib in SCLC at the frontline.
Therefore, this study aimed to analyze real-world data on anlotinib to evaluate whether anlotinib …

… Anlotinib is a novel tyrosine kinase inhibitor with promising anti-tumor activity in patients with
… efficacy and safety of anlotinib combined with liposomal doxorubicin followed by anlotinib …